$506.04
1.620.32%
Ult. Agg.: Nov 12, 6:31 AM
HCA Healthcare rose 6.8% from $473.61 to $506.04, behind the S&P 500's +11.2%. Its worst day was Apr 24 (−8.8%), and its low came Jun 8 at $361.32.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $8.01 beat the $7.42 estimate on $19.5B revenue (est. $19.7B); FY revenue guidance of $76.5B–$80.0B against the $79.2B consensus.
+7.1% · S&P 500 +0.4%
Story events cover the past 12 months · Times ET
HCA Healthcare shares rose 5.9%, while the S&P 500 fell 0.0%.
+5.9% · S&P 500 0.0%
HCA Healthcare closed at its highest level of the year, 15.1% above where the year started.
+2.3% · S&P 500 +0.9%
EPS of $7.15 missed the $7.16 estimate on $19.1B revenue (est. $19.1B); FY revenue guidance of $76.5B–$80.0B against the $78.6B consensus.
−8.8%, the year's worst day · S&P 500 +0.8%
HCA Healthcare closed at its lowest level of the year, 23.7% below where the year started.
−2.9% · S&P 500 +0.2%
HCA Healthcare shares fell 6.9%, while the S&P 500 rose 0.4%.
−6.9% · S&P 500 +0.4%
EPS of $7.59 beat the $7.41 estimate on $20.2B revenue (est. $19.4B); FY revenue guidance of $77.0B–$79.5B against the $78.6B consensus.
+1.5% · S&P 500 +0.1%
HCA Healthcare shares rose 5.6%, while the S&P 500 rose 0.4%.
+5.6% · S&P 500 +0.4%
EPS of $7.22 beat the $6.65 estimate on $19.8B revenue (est. $19.3B); FY revenue guidance of $78.3B–$79.5B against the $78.5B consensus.
−3.3% · S&P 500 +0.6%
HCA Healthcare shares rose 10.3%, while the S&P 500 rose 1.7%.
+10.3%, the year's best day · S&P 500 +1.7%
Where it ended: a close of $506.04 on Nov 11, 2026. Up next: Q4 2026 earnings on Jan 26, 2027 (EPS est. $8.19, revenue est. $20.0B).
As of the Nov 11, 2026 close
Replay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for HCA and SPY from Benzinga historical bars. Not investment advice.